WO2010036979A3 - Novel vectors for production of interferon - Google Patents

Novel vectors for production of interferon Download PDF

Info

Publication number
WO2010036979A3
WO2010036979A3 PCT/US2009/058498 US2009058498W WO2010036979A3 WO 2010036979 A3 WO2010036979 A3 WO 2010036979A3 US 2009058498 W US2009058498 W US 2009058498W WO 2010036979 A3 WO2010036979 A3 WO 2010036979A3
Authority
WO
WIPO (PCT)
Prior art keywords
ifn
interferon
production
vectors
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/058498
Other languages
French (fr)
Other versions
WO2010036979A2 (en
Inventor
William C. Fioretti
Richard K. Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TransGenRx Inc
Louisiana State University
Original Assignee
TransGenRx Inc
Louisiana State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TransGenRx Inc, Louisiana State University filed Critical TransGenRx Inc
Priority to EP09815462A priority Critical patent/EP2342224A2/en
Publication of WO2010036979A2 publication Critical patent/WO2010036979A2/en
Publication of WO2010036979A3 publication Critical patent/WO2010036979A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/30—Bird
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/40—Vector systems having a special element relevant for transcription being an insulator
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/90—Vector systems having a special element relevant for transcription from vertebrates avian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/10—Vectors comprising a special translation-regulating system regulates levels of translation
    • C12N2840/105—Vectors comprising a special translation-regulating system regulates levels of translation enhancing translation

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Novel compositions for the production of interferons such as interferon-α 2a, interferon-α 2b, or interferon-β 1a (IFN-α 2a, IFN-α 2b, or IFN-β 1a) are provided. The compositions comprise components of vectors, such as a vector backbone, a promoter, and a gene of interest that encodes an interferon such as IFN-α 2a, IFN-α 2b, or IFN-β 1a, and the vectors comprising these components. In certain embodiments, these vectors are transposon-based vectors. Also provided are methods of making these compositions and methods of using these compositions for the production of an interferon such as IFN-α 2a, IFN-α 2b, or IFN-β 1a.
PCT/US2009/058498 2008-09-25 2009-09-25 Novel vectors for production of interferon Ceased WO2010036979A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09815462A EP2342224A2 (en) 2008-09-25 2009-09-25 Novel vectors for production of interferon

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10011608P 2008-09-25 2008-09-25
US61/100,116 2008-09-25

Publications (2)

Publication Number Publication Date
WO2010036979A2 WO2010036979A2 (en) 2010-04-01
WO2010036979A3 true WO2010036979A3 (en) 2010-11-18

Family

ID=42058135

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/058498 Ceased WO2010036979A2 (en) 2008-09-25 2009-09-25 Novel vectors for production of interferon

Country Status (3)

Country Link
US (1) US20100081789A1 (en)
EP (1) EP2342224A2 (en)
WO (1) WO2010036979A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9150881B2 (en) 2009-04-09 2015-10-06 Proteovec Holding, L.L.C. Production of proteins using transposon-based vectors

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040172667A1 (en) * 2002-06-26 2004-09-02 Cooper Richard K. Administration of transposon-based vectors to reproductive organs
US8071364B2 (en) * 2003-12-24 2011-12-06 Transgenrx, Inc. Gene therapy using transposon-based vectors
WO2010036978A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of growth hormone
WO2010036976A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of antibodies
WO2012051615A1 (en) 2010-10-15 2012-04-19 Transgenrx, Inc. Novel vectors for production of glycosylated interferon
WO2013050631A1 (en) 2011-10-07 2013-04-11 Crem International Spain, S.L. Device for preparing and dispensing a liquid infusion for professional coffee machines

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004003157A2 (en) * 2002-06-26 2004-01-08 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
WO2004065581A2 (en) * 2003-01-15 2004-08-05 Discovery Genomics, Inc. Transposon-insulator element delivery systems
WO2004067707A2 (en) * 2003-01-21 2004-08-12 Transgenrx, Inc. Administration of transposon-based vectors to reproductive organs

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670388A (en) * 1982-12-30 1987-06-02 Carnegie Institution Of Washington Method of incorporating DNA into genome of drosophila
US4914025A (en) * 1985-12-05 1990-04-03 Colin Manoil Export of intra-cellular substances
US5861478A (en) * 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
US5137829A (en) * 1987-10-05 1992-08-11 Washington University DNA transposon TN5SEQ1
US5212080A (en) * 1987-10-05 1993-05-18 Washington University Method of DNA sequencing using DNA transposon Tn5seql
US5102797A (en) * 1989-05-26 1992-04-07 Dna Plant Technology Corporation Introduction of heterologous genes into bacteria using transposon flanked expression cassette and a binary vector system
US5753502A (en) * 1993-08-05 1998-05-19 Icos Corporation Neuron-specific ICAM-4 promoter
AU3597093A (en) * 1992-01-27 1993-09-01 Embrex Inc. Gene transfer in poultry by introduction of embryo cells (in ovo)
CA2149326C (en) * 1992-11-13 2007-04-17 Mitchell E. Reff Fully impaired consensus kozak sequences for mammalian expression
US20030074680A1 (en) * 1993-03-19 2003-04-17 Johns Hopkins University School Of Medicine Growth differentiation factor-8
US5645991A (en) * 1993-05-04 1997-07-08 Univ. Of Connecticut Transposon-containing DNA cloning vector and uses thereof
US5512483A (en) * 1993-05-21 1996-04-30 Mcgill University Expression vectors responsive to steroid hormones
AU7321294A (en) * 1993-06-30 1995-01-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College, The Transformed eukaryotic cells, and transposon-based transformation vectors
US5648244A (en) * 1993-09-27 1997-07-15 President And Fellows Of Harvard College Production, purification, cleavage and use of fusion peptides
US5827690A (en) * 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
US5843705A (en) * 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
EP0937098B1 (en) * 1995-06-07 2002-08-14 Invitrogen Corporation Recombinational cloning in vitro using engineered recombination sites
US6261554B1 (en) * 1995-07-25 2001-07-17 Introgene B.V. Compositions for targeted gene delivery
US6218185B1 (en) * 1996-04-19 2001-04-17 The United States Of America As Represented By The Secretary Of Agriculture Piggybac transposon-based genetic transformation system for insects
EP0909277B2 (en) * 1996-06-07 2008-12-24 Poniard Pharmaceuticals, Inc. Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
US6825396B2 (en) * 1996-06-12 2004-11-30 Board Of Trustees Operating Michigan State University Methods for tissue specific synthesis of protein in eggs of transgenic hens
EP0919121A4 (en) * 1996-07-08 2000-11-22 Dnavec Research Inc In vivo electroporation method for early animal embryo
WO1998007830A2 (en) * 1996-08-22 1998-02-26 The Institute For Genomic Research COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
US5925545A (en) * 1996-09-09 1999-07-20 Wisconsin Alumni Research Foundation System for in vitro transposition
US6107477A (en) * 1996-09-26 2000-08-22 Aurora Biosciences Corporation Non-optimal Kozaks sequences
US6528699B1 (en) * 1997-02-25 2003-03-04 Genzyme Transgenics Corporation Transgenically produced non-secreted proteins
DK0973928T3 (en) * 1997-03-11 2010-08-09 Univ Minnesota DNA-based transposon system for introducing nucleic acid into DNA in a cell
US6080912A (en) * 1997-03-20 2000-06-27 Wisconsin Alumni Research Foundation Methods for creating transgenic animals
CA2297375A1 (en) * 1997-07-24 1999-02-04 Valentis, Inc. Ghrh expression system and methods of use
US20030115622A1 (en) * 1997-08-04 2003-06-19 Ponce De Leon F. Abel Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgc's, use thereof for cloning and chimerization
US6716823B1 (en) * 1997-08-13 2004-04-06 The Uab Research Foundation Noninvasive genetic immunization, expression products therefrom, and uses thereof
US6897066B1 (en) * 1997-09-26 2005-05-24 Athersys, Inc. Compositions and methods for non-targeted activation of endogenous genes
US7129390B2 (en) * 1997-10-16 2006-10-31 Avigenics, Inc Poultry Derived Glycosylated Interferon Alpha 2b
AU752946B2 (en) * 1997-10-16 2002-10-03 Avigenics, Inc. Vectors comprising a magnum-specific promoter for avian transgenesis
US20020053092A1 (en) * 1997-11-14 2002-05-02 Readhead Carol W. Nucleic acid constructs containing a cyclin A1 promoter, and kit
ATE426036T1 (en) * 1997-11-14 2009-04-15 Cedars Sinai Medical Center TRANSFECTION AND TRANSFER OF NON-HUMAN MALE GERM CELLS TO GENERATE TRANSGENIC NON-HUMAN MAMMALS
TW445295B (en) * 1997-12-31 2001-07-11 Shiu Li Wei Expression vector pcDNA3.1-HC for human erythropoietin, BHK-21 host cell line transformed therewith, and production of human erythropoietin using the transformed cell
US6022716A (en) * 1998-04-10 2000-02-08 Genset Sa High throughput DNA sequencing vector
US6291214B1 (en) * 1998-05-11 2001-09-18 Glaxo Wellcome Inc. System for generating recombinant viruses
US20020013955A1 (en) * 1998-06-10 2002-01-31 Sharon Ogden Production of recombinant protein in transgenic fish
HK1044174A1 (en) * 1998-08-11 2002-10-11 夏威夷大学 Mammalian transgenesis by intracytoplasmic sperm injection
US6514728B1 (en) * 1998-11-09 2003-02-04 Nippon Biocaptal Limited Process for preparation of cytokines using Sendai virus expression system
US7160682B2 (en) * 1998-11-13 2007-01-09 Regents Of The University Of Minnesota Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
AU1750800A (en) * 1998-12-04 2000-06-19 Duke University Purified and isolated (piwi) family genes and gene products and methods employing same
AU4806100A (en) * 1999-04-28 2000-11-10 Board Of Trustees Of The Leland Stanford Junior University P element derived vector and methods for its use
US6518481B1 (en) * 1999-08-12 2003-02-11 Exelixis, Inc. Universal markers of transgenesis
US6773914B1 (en) * 1999-08-19 2004-08-10 The United States Of America As Represented By The Secretary Of Agriculture PiggyBac transformation system
US20020055172A1 (en) * 1999-10-07 2002-05-09 Harrington John J. Multiple promoter expression constructs and methods of use
JP4609869B2 (en) * 1999-12-03 2011-01-12 独立行政法人科学技術振興機構 Transposon transferase and gene modification method
ATE391789T1 (en) * 1999-12-10 2008-04-15 Invitrogen Corp USE OF A VARIETY OF RECOMBINATION SITE WITH UNIQUE SPECIFICITY IN RECOMBINATORY CLONING
CA2394367C (en) * 1999-12-15 2014-01-21 Regents Of The University Of Minnesota Method to enhance agrobacterium-mediated transformation of plants
US20030150007A1 (en) * 2000-03-21 2003-08-07 Charalambos Savakis Method of generating transgenic organisms using transposons
JP2003535122A (en) * 2000-06-02 2003-11-25 ザイコス インク． Delivery system for bioactive substances
US20020028488A1 (en) * 2000-06-19 2002-03-07 Sujay Singh Transgenic avian species for making human and chimeric antibodies
JP2002078491A (en) * 2000-06-22 2002-03-19 National Institute Of Agrobiological Sciences Insertion sequence element derived from ralstonia solanacearum
US6852510B2 (en) * 2000-07-03 2005-02-08 Gala Design Inc Host cells containing multiple integrating vectors
AU2001271912A1 (en) * 2000-07-07 2002-01-21 Maxygen, Inc. Molecular breeding of transposable elements
IL154751A0 (en) * 2000-08-03 2003-10-31 Humanized antibodies, recombination vectors, transgenic vectors and methods for the preparation of humanized antibodies from transgenic animals
GB2368064B (en) * 2000-09-30 2002-11-13 Imp Cancer Res Tech DNA Element and Associated Protein
US20020108132A1 (en) * 2001-02-02 2002-08-08 Avigenics Inc. Production of a monoclonal antibody by a transgenic chicken
US20020119573A1 (en) * 2001-02-28 2002-08-29 Shaw Karen J. Footprinting plasmid
WO2002079447A2 (en) * 2001-03-30 2002-10-10 Avigenics, Inc. Avian lysozyme promoter
JP3723839B2 (en) * 2001-06-07 2005-12-07 国立大学法人広島大学 Chicken leukemia inhibitory factor (LIF) and gene encoding the same
US20030138403A1 (en) * 2001-06-29 2003-07-24 Maxygen Aps Interferon formulations
EP1425400B1 (en) * 2001-09-13 2016-11-02 California Institute Of Technology Method for producing transgenic animals
WO2003025146A2 (en) * 2001-09-18 2003-03-27 Avigenics, Inc. Production of a transgenic avian by cytoplasmic injection
US20030061629A1 (en) * 2001-09-21 2003-03-27 Pramod Sutrave Production of transgenic birds using stage X primordial germ cells
US20030143740A1 (en) * 2001-10-15 2003-07-31 Christine Wooddell Processes for transposase mediated integration into mammalian cells
US20040018624A1 (en) * 2001-10-22 2004-01-29 Athersys, Inc. Compositions and methods for making mutations in cell lines and animals
US6875588B2 (en) * 2001-11-30 2005-04-05 Avigenics, Inc. Ovomucoid promoter and methods of use
US7294507B2 (en) * 2001-11-30 2007-11-13 Avigenics, Inc. Ovomucoid promoters and methods of use
US7335761B2 (en) * 2001-11-30 2008-02-26 Avigenics, Inc. Avian gene expression controlling regions
US20030121062A1 (en) * 2001-12-21 2003-06-26 Oxford Biomedica (Uk) Limited Transgenic organism
CN1620508A (en) * 2001-12-21 2005-05-25 牛津生物医学（英国）有限公司 Transgenic organism
US20040110143A1 (en) * 2002-12-09 2004-06-10 Isis Pharmaceuticals Inc. Modulation of fetoprotein transcription factor expression
EP1501925A4 (en) * 2002-05-17 2006-10-25 New Horizons Diagnostics Corp IDENTIFICATION OF A PHAGEN-ASSOCIATED LYTICAL ENZYME FOR THE FAST AND SPECIFIC DETECTION AND BUTTERFLY OF BACILLUS ANTHRACIS
CN1980571A (en) * 2003-01-24 2007-06-13 阿维季尼克斯股份有限公司 Foreign proteins expressed in poultry and poultry eggs
US20050034186A1 (en) * 2003-03-07 2005-02-10 Harvey Alex J. Site specific nucleic acid integration
WO2004080162A2 (en) * 2003-03-07 2004-09-23 Avigenics, Inc. Integrase mediated avian transgenesis
US7381712B2 (en) * 2003-05-09 2008-06-03 Avigenics, Inc. In vivo transfection in avians
WO2005003359A1 (en) * 2003-07-08 2005-01-13 Japan Science And Technology Corporation Method and system of constructing transgenic organism
US8071364B2 (en) * 2003-12-24 2011-12-06 Transgenrx, Inc. Gene therapy using transposon-based vectors
US20060123504A1 (en) * 2004-12-07 2006-06-08 Avigenics, Inc. Methods of producing polyclonal antibodies
US20060046248A1 (en) * 2004-08-25 2006-03-02 Avigenics, Inc. RNA interference in avians
EP1819823A2 (en) * 2004-12-01 2007-08-22 Bayer Schering Pharma Aktiengesellschaft Generation of replication competent viruses for therapeutic use
WO2010036978A2 (en) * 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of growth hormone
WO2010036976A2 (en) * 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of antibodies

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004003157A2 (en) * 2002-06-26 2004-01-08 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
WO2004065581A2 (en) * 2003-01-15 2004-08-05 Discovery Genomics, Inc. Transposon-insulator element delivery systems
WO2004067707A2 (en) * 2003-01-21 2004-08-12 Transgenrx, Inc. Administration of transposon-based vectors to reproductive organs

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] Derwent; 13 December 2007 (2007-12-13), BLATT LM ET AL: "Human variant interferon-alpha 2b DNA SEQ ID NO: 1818", XP002601424, Database accession no. ANK85305 *
DATABASE Geneseq [online] Derwent; 13 December 2007 (2007-12-13), BLATT LM ET AL: "Human variant interferon-alpha 2b protein SEQ ID NO: 1440.", XP002601423, Database accession no. ANK84991 *
GEYER P K ET AL: "Protecting against promiscuity: The regulatory role of insulators", CMLS CELLULAR AND MOLECULAR LIFE SCIENCES, BIRKHAUSER VERLAG, HEIDELBERG, DE LNKD- DOI:10.1007/S000180200011, vol. 59, no. 12, 1 December 2002 (2002-12-01), pages 2112 - 2127, XP002573586, ISSN: 1420-682X *
KOZAK ET AL: "At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB LNKD- DOI:10.1016/0022-2836(87)90418-9, vol. 196, no. 4, 20 August 1987 (1987-08-20), pages 947 - 950, XP024010432, ISSN: 0022-2836, [retrieved on 19870820] *
LARGAESPADA DAVID A: "Generating and manipulating transgenic animals using transposable elements", REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, XX, XX LNKD- DOI:10.1186/1477-7827-1-80, vol. 1, no. 1, 7 November 2003 (2003-11-07), pages 80, XP021009352, ISSN: 1477-7827 *
MAKSIMENKO O G ET AL: "Insulators of higher eukaryotes: properties, mechanisms of action, and role in transcriptional regulation", RUSSIAN JOURNAL OF GENETICS, MOSCOW, RU, vol. 42, no. 8, 1 August 2006 (2006-08-01), pages 845 - 857, XP002573587, ISSN: 1022-7954 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9150881B2 (en) 2009-04-09 2015-10-06 Proteovec Holding, L.L.C. Production of proteins using transposon-based vectors

Also Published As

Publication number Publication date
US20100081789A1 (en) 2010-04-01
WO2010036979A2 (en) 2010-04-01
EP2342224A2 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
WO2019002512A3 (en) Engineered and fully-functional customized glycoproteins
IL290118A (en) Interleukin-2 variants, fusion proteins comprising same, compositions comprising same and uses thereof
WO2010120514A3 (en) Antigen-binding proteins comprising recombinant protein scaffolds
IL187293A (en) Methods for producing n-linked glycosylated proteins and host prokaryotic organisms
WO2008030614A3 (en) Suppressor trna transcription in vertebrate cells
WO2010011735A3 (en) Modified bovine g-csf polypeptides and their uses
MX2009002524A (en) Site specific incorporation of non-natural amino acids by vertebrate cells.
UA93349C2 (en) Method of stabilizing interferon monomeric protein
WO2013040093A3 (en) Glucagon-like peptide-2 compositions and methods of making and using same
WO2010007622A3 (en) Long-acting interferons and derivatives thereof and methods thereof
WO2008137471A3 (en) Modified interferon beta polypeptides and their uses
WO2006110551A3 (en) Pharmaceutical formulations comprising incretin peptide and aprotic polar solvent
WO2015048345A3 (en) Compositions and formulations for prevention and reduction of tumorigenesis, cancer cell proliferation and invasion, and methods of production and use thereof in cancer treatment
EP1909822A4 (en) Recombinant interferon alpha 2 (ifn alpha 2) mutants
WO2013102144A3 (en) Ph20 polypeptide variants, formulations and uses thereof
WO2005121331A8 (en) Truncated galnact2 polypeptides and nucleic acids
WO2011035319A3 (en) Self-assembling poly(diol citrates)-protein hydrogels
WO2008127664A3 (en) Wheat protein and methods of production
WO2007134325A3 (en) Methods and compositions for protein production using adenoviral vectors
WO2010002160A3 (en) Gene of porcine alpha-s1 casein, a promoter of the same and use thereof
WO2010098561A3 (en) Novel beta-galactosidase having a high transglycosylation activity, and a use therefor
WO2004039834A3 (en) Recombinant protein variants
EP1868636A4 (en) Uses of recombinant super-compound interferons
WO2006041897A3 (en) Chimeric vectors
WO2009125999A3 (en) Human host cell for producing recombinant proteins with high quality and quantity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09815462

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009815462

Country of ref document: EP